Skip to main content

Loss of Pregnancy in a Patient with Chronic Myeloid Leukemia During Treatment with Nilotinib

Audiocasts - Original Research

Justin Arnall, PharmD, discusses the clinical significance of his research and case study on, “Loss of Pregnancy in a Patient with Chronic Myeloid Leukemia During Treatment with Nilotinib.”

Related Items
Arthralgia Rates and Treatment Among Patients Receiving Bevacizumab-awwb Versus Bevacizumab
JHOP - August 2026 Vol 16, No 4 published on April 3, 2026 in Original Research, Adverse Events, Biosimilars
Glucarpi-CAP: A Retrospective Case Series of 1000-Unit Glucarpidase Dosing for Methotrexate Rescue
JHOP - December 2026 Vol 16, No 6 published on March 31, 2026 in Original Research, Methotrexate, Case Reports
Expanding Bispecific T-Cell Engager Therapy for Multiple Myeloma to Community Settings: A Single-Institution Experience
JHOP - December 2026 Vol 16, No 6 published on March 26, 2026 in Original Research, Bispecific Antibodies, Multiple Myeloma
Characterization of A Dose-Dense Doxorubicin and Cyclophosphamide Regimen for Triple-Negative Breast Cancer Within the KEYNOTE-522 Trial
JHOP - December 2026 Vol 16, No 6 published on March 25, 2026 in Original Research, Immunotherapy, Chemotherapy, Breast Cancer
Characterizing Lenalidomide Dose Modifications Among Black and Non-Black Patients Receiving Induction Therapy for Newly Diagnosed Multiple Myeloma
JHOP - October 2026 Vol 16, No 5 published on March 23, 2026 in Original Research, Adverse Events, Disparities in Oncology Care, Dose Escalation/Reduction, Immunotherapy, Multiple Myeloma
Outcomes of Early Versus Delayed Initiation of Immunotherapy in Patients With Extensive-Stage Small Cell Lung Cancer
JHOP - August 2026 Vol 16, No 4 published on March 11, 2026 in Original Research, Lung Cancer, Immunotherapy, Adverse Events
Impact of Hyperglycemia During Immune Checkpoint Inhibitor Treatment for Advanced Non–Small Cell Lung Cancer: A Retrospective, Single-Center Study
JHOP - June 2026 Vol 16, No 3 published on February 25, 2026 in Original Research, Checkpoint Inhibitors, Adverse Events, Lung Cancer
Management Patterns and Perceived Educational Needs Related to Cancer Therapy Cardiovascular Toxicities for Cardio-Oncology Providers
JHOP - June 2026 Vol 16, No 3 published on February 19, 2026 in Original Research, Adverse Events, Drug–Drug Interaction
Risk for Vincristine-Induced Adverse Events With Aprepitant in Pediatric Patients With Rhabdomyosarcoma
JHOP - April 2026 Vol 16, No 2 published on January 20, 2026 in Original Research, Adverse Events, Chemotherapy, Drug–Drug Interaction
Infusion-Related Reactions Associated With Nivolumab and Pembrolizumab: A Case Series Analysis
JHOP - June 2026 Vol 16, No 3 published on January 8, 2026 in Original Research, Checkpoint Inhibitors, Infusion Issues, PD-1 Inhibitors